Facing intense lobbying by pharmaceutical and hospital groups, lawmakers of the House Energy and Commerce Committee struggle to find a middle ground as they propose options for the upcoming 340B legislation.Original Article
Hospital and pharma jockeying over 340B puts lawmakers into a tight spot
